Regulators in EU, Japan and US take steps to facilitate development of new antibiotics By Anna Jurczynska | June 28, 2017 Posted in Recent News ← DEVELOPMENT OF PHARMACEUTICAL MEDICINE IN IRELANDNew action plan to support SMEs as drivers of pharmaceutical innovation →